QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 8, 2005, 25(23):5544-5552; doi:10.1523/JNEUROSCI.0482-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Smith, W. W. Articles by Ross, C. A. Search for Related Content PubMed PubMed Citation Articles by Smith, W. W. Articles by Ross, C. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Genetics Home Reference Hazardous Substances DB HYDROGEN PEROXIDE

 Previous Article  |  Next Article 

Neurobiology of Disease
-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells

Wanli W. Smith,¹ Russell L. Margolis,¹ Xiaojie Li,^2,6 Juan C. Troncoso,³ Michael K. Lee,³ Valina L. Dawson,^2,4,5,6 Ted M. Dawson,^2,4,6 Takashi Iwatsubo,⁷ and Christopher A. Ross^1,2,4

Departments of ¹Psychiatry, ²Neurology, ³Pathology, ⁴Neuroscience, and ⁵Physiology, and ⁶Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and ⁷Department of Neuropathology and Neuroscience, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan

Parkinson's disease (PD) is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons and the presence of Lewy bodies. Previous reports have shown that -synuclein deposited in brain tissue from individuals with synucleinopathy is extensively phosphorylated at Ser-129. Here, we investigate the role of phosphorylation of -synuclein in the formation of inclusions involving synphilin-1 and parkin using site-directed mutagenesis to change Ser-129 of -synuclein to alanine (S129A) to abolish phosphorylation at this site. Coexpression of wild-type -synuclein and synphilin-1 in human neuroblastoma SH-SY5Y cells yielded cytoplasmic eosinophilic inclusions with some features resembling Lewy bodies, whereas coexpression of S129A -synuclein and synphlin-1 formed few or no inclusions. Moreover, coexpression of parkin with -synuclein and synphilin-1 formed more ubiquitinated inclusions, but these inclusions decreased with expression of S129A -synuclein instead of wild-type -synuclein. Coimmunoprecipitation assays revealed a decreased interaction of S129A -synuclein with synphilin-1 compared with wild-type -synuclein. Expression of S129A -synuclein instead of wild-type -synuclein also decreased the association of synphilin-1 and parkin and subsequently reduced the parkin-mediated ubiquitination of synphilin-1 and the formation of ubiquitinated inclusions. Treatment of SH-SY5Y cells with H₂O₂ increased -synuclein phosphorylation and enhanced the formation of inclusions formed by coexpression of -synuclein, synphilin-1, and parkin, whereas treatment with the casein kinase 2 inhibitor 5,6-dichloro-1--D-ribofuranosylbenzimidazole had the opposite affect. These results indicate that phosphorylation of -synuclein at S129 may be important for the formation of inclusions in PD and related synucleinopathies.

Key words: -synuclein; Parkinson's disease; synphilin-1; parkin; ubiquitin; eosinophilic inclusion; Lewy body

---

Received June 3, 2004; revised April 26, 2005; accepted May 1, 2005.

This article has been cited by other articles:

				S. Azeredo da Silveira, B. L. Schneider, C. Cifuentes-Diaz, D. Sage, T. Abbas-Terki, T. Iwatsubo, M. Unser, and P. Aebischer Phosphorylation does not prompt, nor prevent, the formation of {alpha}-synuclein toxic species in a rat model of Parkinson's disease Hum. Mol. Genet., March 1, 2009; 18(5): 872 - 887. [Abstract] [Full Text] [PDF]

				N. Sugeno, A. Takeda, T. Hasegawa, M. Kobayashi, A. Kikuchi, F. Mori, K. Wakabayashi, and Y. Itoyama Serine 129 Phosphorylation of {alpha}-Synuclein Induces Unfolded Protein Response-mediated Cell Death J. Biol. Chem., August 22, 2008; 283(34): 23179 - 23188. [Abstract] [Full Text] [PDF]

				H.-M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, and V. M.-Y. Lee Neuroinflammation and Oxidation/Nitration of {alpha}-Synuclein Linked to Dopaminergic Neurodegeneration J. Neurosci., July 23, 2008; 28(30): 7687 - 7698. [Abstract] [Full Text] [PDF]

				K. E. Paleologou, A. W. Schmid, C. C. Rospigliosi, H.-Y. Kim, G. R. Lamberto, R. A. Fredenburg, P. T. Lansbury Jr., C. O. Fernandez, D. Eliezer, M. Zweckstetter, et al. Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of {alpha}-Synuclein J. Biol. Chem., June 13, 2008; 283(24): 16895 - 16905. [Abstract] [Full Text] [PDF]

				J. T. Lee, T. C. Wheeler, L. Li, and L.-S. Chin Ubiquitination of {alpha}-synuclein by Siah-1 promotes {alpha}-synuclein aggregation and apoptotic cell death Hum. Mol. Genet., March 15, 2008; 17(6): 906 - 917. [Abstract] [Full Text] [PDF]

				R. Rott, R. Szargel, J. Haskin, V. Shani, A. Shainskaya, I. Manov, E. Liani, E. Avraham, and S. Engelender Monoubiquitylation of {alpha}-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells J. Biol. Chem., February 8, 2008; 283(6): 3316 - 3328. [Abstract] [Full Text] [PDF]

				K. Assayag, E. Yakunin, V. Loeb, D. J. Selkoe, and R. Sharon Polyunsaturated Fatty Acids Induce {alpha}-Synuclein-Related Pathogenic Changes in Neuronal Cells Am. J. Pathol., December 1, 2007; 171(6): 2000 - 2011. [Abstract] [Full Text] [PDF]

				H. Kaneko, A. Kakita, K. Kasuga, H. Nozaki, A. Ishikawa, A. Miyashita, R. Kuwano, G. Ito, T. Iwatsubo, H. Takahashi, et al. Enhanced Accumulation of Phosphorylated {alpha}-Synuclein and Elevated -Amyloid 42/40 Ratio Caused by Expression of the Presenilin-1 {Delta}T440 Mutant Associated with Familial Lewy Body Disease and Variant Alzheimer's Disease J. Neurosci., November 28, 2007; 27(48): 13092 - 13097. [Abstract] [Full Text] [PDF]

				W. S. Woods, J. M. Boettcher, D. H. Zhou, K. D. Kloepper, K. L. Hartman, D. T. Ladror, Z. Qi, C. M. Rienstra, and J. M. George Conformation-specific Binding of {alpha}-Synuclein to Novel Protein Partners Detected by Phage Display and NMR Spectroscopy J. Biol. Chem., November 23, 2007; 282(47): 34555 - 34567. [Abstract] [Full Text] [PDF]

				B. Thomas and M. F. Beal Parkinson's disease Hum. Mol. Genet., October 15, 2007; 16(R2): R183 - R194. [Abstract] [Full Text] [PDF]

				J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies J. Biol. Chem., September 28, 2007; 282(39): 28904 - 28914. [Abstract] [Full Text] [PDF]

				C. Liu, E. Fei, N. Jia, H. Wang, R. Tao, A. Iwata, N. Nukina, J. Zhou, and G. Wang Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated {alpha}-Synuclein Implies Lewy Body Biogenesis J. Biol. Chem., May 11, 2007; 282(19): 14558 - 14566. [Abstract] [Full Text] [PDF]

				E. Avraham, R. Rott, E. Liani, R. Szargel, and S. Engelender Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation J. Biol. Chem., April 27, 2007; 282(17): 12842 - 12850. [Abstract] [Full Text] [PDF]

				E. J. Kim, J. Y. Sung, H. J. Lee, H. Rhim, M. Hasegawa, T. Iwatsubo, D. S. Min, J. Kim, S. R. Paik, and K. C. Chung Dyrk1A Phosphorylates {alpha}-Synuclein and Enhances Intracellular Inclusion Formation J. Biol. Chem., November 3, 2006; 281(44): 33250 - 33257. [Abstract] [Full Text] [PDF]

				J. P. Anderson, D. E. Walker, J. M. Goldstein, R. de Laat, K. Banducci, R. J. Caccavello, R. Barbour, J. Huang, K. Kling, M. Lee, et al. Phosphorylation of Ser-129 Is the Dominant Pathological Modification of {alpha}-Synuclein in Familial and Sporadic Lewy Body Disease J. Biol. Chem., October 6, 2006; 281(40): 29739 - 29752. [Abstract] [Full Text] [PDF]

				J. R. Mazzulli, A. J. Mishizen, B. I. Giasson, D. R. Lynch, S. A. Thomas, A. Nakashima, T. Nagatsu, A. Ota, and H. Ischiropoulos Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates J. Neurosci., September 27, 2006; 26(39): 10068 - 10078. [Abstract] [Full Text] [PDF]

				S. Arawaka, M. Wada, S. Goto, H. Karube, M. Sakamoto, C.-H. Ren, S. Koyama, H. Nagasawa, H. Kimura, T. Kawanami, et al. The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease J. Neurosci., September 6, 2006; 26(36): 9227 - 9238. [Abstract] [Full Text] [PDF]

				A. H.V. Schapira Etiology of Parkinson's disease Neurology, May 23, 2006; 66(10_suppl_4): S10 - S23. [Abstract] [Full Text]

				C. W. Shults Lewy bodies PNAS, February 7, 2006; 103(6): 1661 - 1668. [Abstract] [Full Text] [PDF]

				T. Kuwahara, A. Koyama, K. Gengyo-Ando, M. Masuda, H. Kowa, M. Tsunoda, S. Mitani, and T. Iwatsubo Familial Parkinson Mutant {alpha}-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans J. Biol. Chem., January 6, 2006; 281(1): 334 - 340. [Abstract] [Full Text] [PDF]

				W. W. Smith, Z. Pei, H. Jiang, D. J. Moore, Y. Liang, A. B. West, V. L. Dawson, T. M. Dawson, and C. A. Ross Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration PNAS, December 20, 2005; 102(51): 18676 - 18681. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help